Last $0.20 USD
Change Today -0.0007 / -0.38%
Volume 18.1K
AXXE On Other Exchanges
Symbol
Exchange
OTC US
As of 10:22 AM 01/30/15 All times are local (Market data is delayed by at least 15 minutes).

axxess pharma inc (AXXE) Snapshot

Open
$0.20
Previous Close
$0.20
Day High
$0.20
Day Low
$0.19
52 Week High
03/21/14 - $0.50
52 Week Low
12/1/14 - $0.12
Market Cap
--
Average Volume 10 Days
453.1K
EPS TTM
--
Shares Outstanding
0.0
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for AXXESS PHARMA INC (AXXE)

Related News

No related news articles were found.

axxess pharma inc (AXXE) Related Businessweek News

No Related Businessweek News Found

axxess pharma inc (AXXE) Details

Axxess Pharma, Inc. is a specialty pharmaceutical and nutritional supplements company that offers select medicines, nutritional supplements, and over the counter remedies in the Americas. The company, through its subsidiary, Axxess Pharma Canada Inc., offers prescription and non-prescription products to improve health-related conditions, including various forms of iron deficiency, bone loss, rheumatoid arthritis, migraine headaches, urinary tract infections, infant cradle cap, joint pain, and more. Its prescription products include Britical, Vivol, Soropon, Somnol, Kemsol, Lactrose, Niaxx, Urasal, Monurol, Axspaz, and Hydraxx; and non-prescription products include Hydraxx 2%, Hydraxx Serum, Potassium Chloride liquid, Hydraxx Serum Eyes, Calcium Citrate with VitaminD, Kemsol for Scleroderma, Soropon Shampoo, and Hydraxx 1%. The company was founded in 1997 and is headquartered in Toronto, Canada.

4 Employees
Last Reported Date: 01/21/15
Founded in 1997

axxess pharma inc (AXXE) Top Compensated Officers

Chief Executive Officer, President, Chief Fin...
Total Annual Compensation: $22.6K
Compensation as of Fiscal Year 2013.

axxess pharma inc (AXXE) Key Developments

Axxess Pharma, Inc. Mulls Acquisition

Axxess Pharma, Inc. (OTCPK:AXXE) is seeking acquisition. Axxess Pharma, Inc. filed a shelf registration. Axxess Pharma said “We will receive proceeds from the sale of securities pursuant to the Investment Agreement. The proceeds received under the Investment Agreement will be used for general corporate and working capital purposes and acquisitions or assets, businesses or operations or for other purposes that the Board of Directors, in its good faith deems to be in the best interest of the Company.”

Axxess Pharma, Inc. Receives Purchase Order from Muscle Foods USA

Axxess Pharma Inc. announced that they have received a purchase order from Muscle Foods USA. The purchase order is for the full line of Axxess Pharma/AllStar Health Brands TapouT products. The purchase order officially places AllStar Health Brands into Muscle Foods USA's distributor system and opens the door for further acceleration of national sales. Muscle Foods USA has a growing distribution base which includes over 3,000 gyms, health clubs, performance stores, health food stores, convenience stores and retail websites.

Axxess and Tapout Fitness Announce Exclusive Alliance to Supply Gyms with Tapout Products

Axxess Pharma Inc. announced an exclusive alliance to supply two TapouT Fitness gyms with TapouT products in the greater Cincinnati and greater Atlanta areas.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AXXE:US $0.20 USD -0.0007

AXXE Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for AXXE.
View Industry Companies
 

Industry Analysis

AXXE

Industry Average

Valuation AXXE Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book NM Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AXXESS PHARMA INC, please visit www.axxesspharmainc.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.